Skip to content Skip to footer
Bivalirudin: Benefits, Reviews, Info, Side Effects!
Rx Details
Bivalirudin
Angiomax, Hirulog
Bivalirudin
Prescription
Anticoagulant
Drugs
Prescription Only
anticoagulation, reduced risk of bleeding compared to heparin, rapid onset and offset of action, predictable pharmacokinetics, no need for routine monitoring, used in patients with heparin-induced thrombocytopenia
Abdominal Pain, Anemia, Anxiety, Back Pain, Bleeding, Bradycardia, Dizziness, Dyspnea, Fever, Headache, Hypertension, Hypotension, Injection Site Reaction, Insomnia, Nausea, Pain, Thrombocytopenia, Vomiting
Bivalirudin is an anticoagulant medication often used during certain types of heart procedures, such as percutaneous coronary intervention (PCI). The dosage of bivalirudin can vary based on the specific clinical situation and patient characteristics. However, a common dosing regimen for bivalirudin during PCI is: – An initial intravenous bolus of 0.75 mg/kg, followed by – A continuous infusion of 1.75 mg/kg/hour for the duration of the procedure. For patients with renal impairment, the infusion rate may need to be adjusted. It’s important to follow specific medical guidance and protocols when administering bivalirudin, as the exact dosage can depend on various factors including the patient’s condition and the procedure being performed. Always consult a healthcare professional for precise dosing information.
Input: bivalirudin output: unstable angina, percutaneous coronary intervention, heparin-induced thrombocytopenia
Generally well-tolerated with low risk of bleeding complications.
No interactions found
$200 – $500
$1,200

A Synopsis of

Bivalirudin

Bivalirudin is a medication that is commonly used in the treatment of patients with certain heart conditions, particularly those undergoing procedures such as angioplasty or stent placement. This medication belongs to a class of drugs known as direct thrombin inhibitors, which work by preventing the formation of blood clots in the arteries.

One of the key benefits of bivalirudin is its ability to provide effective anticoagulation while minimizing the risk of bleeding complications compared to other anticoagulants. This makes it a preferred choice for patients who may be at higher risk for bleeding, such as those with a history of gastrointestinal bleeding or other bleeding disorders.

It is important to note that bivalirudin should only be used under the supervision of a healthcare provider, as it requires careful monitoring of blood clotting parameters to ensure that the patient is receiving the appropriate dose. Your healthcare provider will determine the correct dosage and duration of treatment based on your individual medical history and the specific procedure being performed.

As with any medication, bivalirudin may cause side effects in some patients. These can include bleeding, allergic reactions, or changes in kidney function. It is important to report any unusual symptoms or side effects to your healthcare provider promptly.

Overall, bivalirudin is a valuable medication in the management of certain heart conditions and can help improve outcomes for patients undergoing invasive cardiac procedures. If you have any questions or concerns about bivalirudin or its use, do not hesitate to discuss them with your healthcare provider.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN